Dickstein K, Larsen A I
Medisinsk avdeling, Sentralsjukehuset i Rogaland, Stavanger.
Tidsskr Nor Laegeforen. 1991 Oct 30;111(26):3180-2.
The role of digitalis therapy in patients with sinus rhythm and mild to moderate heart failure has been a subject of controversy. This review critically examines the relevant literature and specifically evaluates trials in this patient population. The pharmacokinetics and the pharmacodynamics of the most commonly prescribed agents are briefly discussed. The available evidence supports the use of this agent in patients with sinus rhythm and clinical signs of systolic dysfunction. Digitalis is not recommended as a routine when the primary cause of heart failure is diastolic dysfunction. The use of digitalis therapy in combination with diuretics and vasodilator therapy deserves further attention.
洋地黄疗法在窦性心律且伴有轻至中度心力衰竭患者中的作用一直存在争议。本综述审慎地审视了相关文献,并特别评估了针对该患者群体的试验。文中简要讨论了最常用药物的药代动力学和药效学。现有证据支持在窦性心律且有收缩功能障碍临床体征的患者中使用该药物。当心力衰竭的主要病因是舒张功能障碍时,不建议将洋地黄作为常规用药。洋地黄疗法与利尿剂和血管扩张剂疗法联合使用值得进一步关注。